Association Between Polymorphisms of OCT1 and Metabolic Response to Metformin in Women with Polycystic Ovary Syndrome

April 2019 in “ International Journal of Molecular Sciences ”

Hui Hua Chang, Yuan-Shuo Hsueh, Yung Wen Cheng, Horng Yih Ou, Meng Hsing Wu

polycystic ovary syndrome PCOS OCT1 OCT2 metformin single nucleotide polymorphisms SNPs insulin sensitivity pharmacogenomic profiles

Studysummary This study found that genetic polymorphisms of OCT1 influence the effectiveness of metformin treatment in improving insulin sensitivity among PCOS patients, suggesting a role for personalized treatment strategies. Our plain-language summary of this paper — not a Tressless recommendation.

The study, involving 87 women with polycystic ovary syndrome (PCOS) and 113 control women, explored the relationship between polymorphisms in OCT1 and OCT2 and the metabolic response to metformin. It was found that certain single nucleotide polymorphisms (SNPs) in OCT1 (rs683369 and rs628031) were associated with increased insulin sensitivity after six months of metformin treatment in PCOS patients. These findings suggest that OCT1 genetic variations can influence the response to metformin, highlighting the potential for personalized treatment strategies based on individual pharmacogenomic profiles. However, the study also recognized limitations such as a small sample size and the need for further research to confirm these results and develop personalized treatment plans.

View this study on mdpi.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Metformin Improved Health-Related Quality of Life in Ethnic Chinese Women with Polycystic Ovary Syndrome

19 citations , August 2016 in “Health and Quality of Life Outcomes”

This study found that metformin treatment may improve health-related quality of life in ethnic Chinese women with polycystic ovary syndrome, particularly in aspects of physical health, acne, and infertility, especially for those who are overweight and have hyperandrogenism.

research Epidemiology, Diagnosis, and Management of Polycystic Ovary Syndrome

951 citations , December 2013 in “Clinical epidemiology”

This article reviews the prevalence, risk factors, and clinical manifestations of polycystic ovary syndrome, highlighting current treatment and management options, but reports no new research findings.

Polycystic Ovary Syndrome: A Complex Condition with Psychological, Reproductive, and Metabolic Manifestations That Impacts Health Across the Lifespan

research Polycystic Ovary Syndrome: A Complex Condition with Psychological, Reproductive, and Metabolic Manifestations That Impacts Health Across the Lifespan

926 citations , June 2010 in “BMC Medicine”

This review emphasizes the need for comprehensive guidelines to address the cardiometabolic and psychological features of polycystic ovary syndrome, alongside its reproductive aspects, and reports no new results.

research Evidence-Based and Potential Benefits of Metformin in Polycystic Ovary Syndrome: A Comprehensive Review

343 citations , December 2008 in “Endocrine Reviews”

This review discusses the various evidence-based and potential applications of metformin in treating and preventing symptoms and complications associated with polycystic ovary syndrome but reports no new clinical results.